Additional PCPT Resources NCI PCPT site Prostate cancer prevention in PDQ

The Prostate Cancer Prevention Trial (PCPT) was a SWOG-coordinated study designed to test whether the drug finasteride (Proscar®) would prevent prostate cancer in men ages 55 and older. This study was closed on June 24, 2003 because the study objective had been reached. The results of the study, which did find a preventive benefit for the drug, were published as "The Influence of Finasteride on the Development of Prostate Cancer," in the New England Journal of Medicine on July 17, 2003.

Approved Projects

You can view the list of projects that have been awarded use of these biorepository resources through a peer-review process.

PCPT Resources

1. Summary of PCPT trial and results (PDF)
2. Summary of P01 grant and other approved or funded projects based on PCPT (PDF)
3. Specimens
   • Blood sample and tissue acquisition protocols (PDF)
   • Tables of available specimens
   • Table of P01 serum samples verified - with volumes (PDF)
   • Table of non-verified serum samples - uknown volumes (PDF)
   • Table of DNA or WBC available (PDF)
   • Table of tissues collected and stored (PDF)
4. Additional PCPT documents
   • Study protocol (PDF, 1.1MB)
   • List of published papers (PDF)
   • Relevant study forms (PDF)
5. PCPT data (all collapsed over arms)
   • Baseline characteristics (PDF)
   • Endpoints
     • Prostate cancers (PDF)
     • Other cancers (PDF)
     • Deaths (PDF)